共 50 条
- [21] Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastasesBreast Cancer Research, 22Jose Pablo LeoneKyrre E. EmblemMichelle WeitzRebecca S. GelmanBryan P. SchneiderRachel A. FreedmanJerry YoungerMarco C. PinhoA. Gregory SorensenElizabeth R. GerstnerGordon HarrisIan E. KropDaniel MorgansternJessica SohlJiani HuElizabeth KasparianEric P. WinerNancy U. Lin
- [22] Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastasesBREAST CANCER RESEARCH, 2020, 22 (01)Leone, Jose PabloEmblem, Kyrre E.Weitz, MichelleGelman, Rebecca S.Schneider, Bryan P.Freedman, Rachel A.Younger, JerryPinho, Marco C.Sorensen, A. GregoryGerstner, Elizabeth R.Harris, GordonKrop, Ian E.Morganstern, DanielSohl, JessicaHu, JianiKasparian, ElizabethWiner, Eric P.Lin, Nancy U.
- [23] A phase II study of anlotinib plus whole brain radiation therapy for patients with NSCLC with multiple brain metastasesANNALS OF MEDICINE, 2024, 56 (01)Gu, DayongYu, HongliangDing, NaixinXu, JianhuaQian, PudongZhu, JunJiang, MingTao, HuaZhu, Xiangzhi
- [24] TBCRC 022: Phase II trial of neratinib plus capecitabine for patients (Pts) with human epidermal growth factor receptor 2 (HER2+) breast cancer brain metastases (BCBM).JOURNAL OF CLINICAL ONCOLOGY, 2017, 35Freedman, Rachel A.Gelman, Rebecca SueMelisko, Michelle E.Anders, Carey K.Moy, BeverlyBlackwell, Kimberly L.Connolly, Roisin M.Niravath, Polly AnnVan Poznak, Catherine H.Puhalla, ShannonFarooq, SarahCropp, AnneCotter, Christine M.Liu, Minetta C.Krop, Ian E.Nangia, Julie R.Tung, Nadine M.Wolff, Antonio C.Winer, Eric P.Lin, Nancy U.
- [25] Graded prognostic assessment index for breast cancer patients with brain metastases (BCBM).JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)Venur, Vyshak AlvaDahiya, SaurabhDu, LinglingGarje, RohanOsei-Boateng, KwabenaElson, PaulSuh, John H.Chao, Samuel T.Ahluwalia, Manmeet Singh
- [26] A phase II trial of bevacizumab in patients with recurrent solid tumor brain metastases who have failed whole brain radiation therapy (WBRT).JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Kumthekar, PriyaDixit, KaranGrimm, Sean AaronLukas, Rimas VincasSchwartz, Margaret A.Rademaker, AlfredSharp, LauraNelson, ValerieRaizer, Jeffrey J.
- [27] Phase I safety and pharmacokinetic (PK) study of veliparib in combination with whole brain radiation therapy (WBRT) in patients (pts) with brain metastasesJOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)Mehta, Minesh P.Curran, Walter J.Wang, DingWang, FenKleinberg, LawrenceBrade, Anthony M.Mostafa, NaelZhou, XiangdongQian, JiangLeahy, TerriDesai, BhardwajGiranda, Vincent L.
- [28] Phase I Safety and Pharmacokinetic (PK) Study of Veliparib in Combination With Whole Brain Radiation Therapy (WBRT) in Patients (pts) With Brain MetastasesINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S269 - S270Mehta, M. P.Curran, W. J.Wang, D.Wang, F.Kleinberg, L.Brade, A.Mostafa, N.Qian, J.Leahy, T.Desai, B.
- [29] PHASE 1 SAFETY AND PHARMACOKINETIC (PK) STUDY OF VELIPARIB IN COMBINATION WITH WHOLE BRAIN RADIATION THERAPY (WBRT) IN PATIENTS (PTS) WITH BRAIN METASTASESJOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S120 - S120Mehta, Minesh P.Curran, Walter J.Wang, DingWang, FenKleinberg, LawrenceBrade, AnthonyMostafa, NaelZhou, XiangdongQian, JiangLeahy, TerriDesai, BhardwajGiranda, Vincent
- [30] Phase I study of lapatinib(L) in combination with whole-brain radiation therapy (WBRT) in patients (pts) with brain metastases from HER2-positive breast cancerJOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)Lin, N. U.Ramakrishna, N.Younger, W. J.Storniolo, A. M.Come, S. E.Gelman, R. S.Eisenberg, E.Winer, E. P.